These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 12892163

  • 21. Structural and functional brain development after hydrocortisone treatment for neonatal chronic lung disease.
    Lodygensky GA, Rademaker K, Zimine S, Gex-Fabry M, Lieftink AF, Lazeyras F, Groenendaal F, de Vries LS, Huppi PS.
    Pediatrics; 2005 Jul; 116(1):1-7. PubMed ID: 15995023
    [Abstract] [Full Text] [Related]

  • 22. Hydrocortisone treatment for bronchopulmonary dysplasia and brain volumes in preterm infants.
    Kersbergen KJ, de Vries LS, van Kooij BJ, Išgum I, Rademaker KJ, van Bel F, Hüppi PS, Dubois J, Groenendaal F, Benders MJ.
    J Pediatr; 2013 Sep; 163(3):666-71.e1. PubMed ID: 23706359
    [Abstract] [Full Text] [Related]

  • 23. [Glucocorticoide therapy in premature infants: French practices in 2006].
    Autret-Leca E, Bauer S, Alberti C, Jonville-Béra AP, Aujard Y, Bensouda-Grimaldi L, Baud O.
    Arch Pediatr; 2009 Jul; 16(7):999-1004. PubMed ID: 19410441
    [Abstract] [Full Text] [Related]

  • 24. Oliguria during hydrocortisone dosage wean in very low birth weight infants.
    Sauberan JB, Reed EM, Vaucher YV, Katheria AC.
    Am J Perinatol; 2014 Sep; 31(8):673-6. PubMed ID: 24108665
    [Abstract] [Full Text] [Related]

  • 25. Early dexamethasone therapy in preterm infants: a follow-up study.
    Yeh TF, Lin YJ, Huang CC, Chen YJ, Lin CH, Lin HC, Hsieh WS, Lien YJ.
    Pediatrics; 1998 May; 101(5):E7. PubMed ID: 9565440
    [Abstract] [Full Text] [Related]

  • 26. Dose-related inhibition of proinflammatory cytokine release from neutrophils of the newborn by dexamethasone, betamethasone, and hydrocortisone.
    Irakam A, Miskolci V, Vancurova I, Davidson D.
    Biol Neonate; 2002 Aug; 82(2):89-95. PubMed ID: 12169830
    [Abstract] [Full Text] [Related]

  • 27. Early postnatal dexamethasone therapy for the prevention of chronic lung disease in preterm infants with respiratory distress syndrome: a multicenter clinical trial.
    Yeh TF, Lin YJ, Hsieh WS, Lin HC, Lin CH, Chen JY, Kao HA, Chien CH.
    Pediatrics; 1997 Oct; 100(4):E3. PubMed ID: 9310536
    [Abstract] [Full Text] [Related]

  • 28. Retrospective Analysis of Short-Term Respiratory Outcomes of Three Different Steroids Used in Clinical Practice in Intubated Preterm Infants.
    Nath S, Reynolds AM, Lakshminrusimha S, Ma C, Hudak ML, Ryan RM.
    Am J Perinatol; 2020 Dec; 37(14):1425-1431. PubMed ID: 31382299
    [Abstract] [Full Text] [Related]

  • 29. Long-term effects of neonatal hydrocortisone treatment for chronic lung disease on the developing brain and heart.
    Rademaker KJ, de Vries WB.
    Semin Fetal Neonatal Med; 2009 Jun; 14(3):171-7. PubMed ID: 19101215
    [Abstract] [Full Text] [Related]

  • 30. Early postnatal dexamethasone treatment and increased incidence of cerebral palsy.
    Shinwell ES, Karplus M, Reich D, Weintraub Z, Blazer S, Bader D, Yurman S, Dolfin T, Kogan A, Dollberg S, Arbel E, Goldberg M, Gur I, Naor N, Sirota L, Mogilner S, Zaritsky A, Barak M, Gottfried E.
    Arch Dis Child Fetal Neonatal Ed; 2000 Nov; 83(3):F177-81. PubMed ID: 11040164
    [Abstract] [Full Text] [Related]

  • 31. Prenatal dexamethasone treatment in conjunction with rescue therapy of human surfactant: a randomized placebo-controlled multicenter study.
    Kari MA, Hallman M, Eronen M, Teramo K, Virtanen M, Koivisto M, Ikonen RS.
    Pediatrics; 1994 May; 93(5):730-6. PubMed ID: 8165070
    [Abstract] [Full Text] [Related]

  • 32. Growth and neurodevelopmental outcomes after early low-dose hydrocortisone treatment in extremely low birth weight infants.
    Watterberg KL, Shaffer ML, Mishefske MJ, Leach CL, Mammel MC, Couser RJ, Abbasi S, Cole CH, Aucott SW, Thilo EH, Rozycki HJ, Lacy CB.
    Pediatrics; 2007 Jul; 120(1):40-8. PubMed ID: 17606560
    [Abstract] [Full Text] [Related]

  • 33. A randomized trial of moderately early low-dose dexamethasone therapy in very low birth weight infants: dynamic pulmonary mechanics, oxygenation, and ventilation.
    Durand M, Mendoza ME, Tantivit P, Kugelman A, McEvoy C.
    Pediatrics; 2002 Feb; 109(2):262-8. PubMed ID: 11826205
    [Abstract] [Full Text] [Related]

  • 34. Controlled trial of dexamethasone in neonatal chronic lung disease: an 8-year follow-up of cardiopulmonary function and growth.
    Mieskonen S, Eronen M, Malmberg LP, Turpeinen M, Kari MA, Hallman M.
    Acta Paediatr; 2003 Aug; 92(8):896-904. PubMed ID: 12948063
    [Abstract] [Full Text] [Related]

  • 35. Outcomes at school age after postnatal dexamethasone therapy for lung disease of prematurity.
    Yeh TF, Lin YJ, Lin HC, Huang CC, Hsieh WS, Lin CH, Tsai CH.
    N Engl J Med; 2004 Mar 25; 350(13):1304-13. PubMed ID: 15044641
    [Abstract] [Full Text] [Related]

  • 36. A randomized trial of two dexamethasone regimens to reduce side-effects in infants treated for chronic lung disease of prematurity.
    Odd DE, Armstrong DL, Teele RL, Kuschel CA, Harding JE.
    J Paediatr Child Health; 2004 Mar 25; 40(5-6):282-9. PubMed ID: 15151582
    [Abstract] [Full Text] [Related]

  • 37. Moderately early (7-14 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants.
    Halliday HL, Ehrenkranz RA, Doyle LW.
    Cochrane Database Syst Rev; 2003 Mar 25; (1):CD001144. PubMed ID: 12535400
    [Abstract] [Full Text] [Related]

  • 38. A multicenter trial of two dexamethasone regimens in ventilator-dependent premature infants.
    Papile LA, Tyson JE, Stoll BJ, Wright LL, Donovan EF, Bauer CR, Krause-Steinrauf H, Verter J, Korones SB, Lemons JA, Fanaroff AA, Stevenson DK.
    N Engl J Med; 1998 Apr 16; 338(16):1112-8. PubMed ID: 9545359
    [Abstract] [Full Text] [Related]

  • 39. Cardiovascular and metabolic side effects associated with hydrocortisone and dexamethasone use in VLBW infants: a single-centre experience.
    Röhr SB, Sauer H, Gortner L, Gräber S, Meyer S.
    Acta Paediatr; 2013 Oct 16; 102(10):e436. PubMed ID: 23819647
    [No Abstract] [Full Text] [Related]

  • 40. Implementing potentially better practices to improve neonatal outcomes after reducing postnatal dexamethasone use in infants born between 501 and 1250 grams.
    Kaempf JW, Campbell B, Sklar RS, Arduza C, Gallegos R, Zabari M, Brown A, McDonald JV.
    Pediatrics; 2003 Apr 16; 111(4 Pt 2):e534-41. PubMed ID: 12671173
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.